This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: E3x Bio, Inc.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Brigit Riley: Innovator in Ubiquitin Ligase Modulation
Introduction
Brigit Riley is a prominent inventor based in Mill Valley, CA (US). She has made significant contributions to the field of biotechnology, particularly in the modulation of ubiquitin ligases. Her innovative work has the potential to impact human health and disease treatment.
Latest Patents
Brigit Riley holds a patent titled "Method for identifying modulators of ubiquitin ligases." This invention provides a screening method that utilizes mechanism-based activity probes. These probes specifically and covalently modify the active site cysteine thiol residue of E3 ubiquitin ligases, including the HECT and RBR families. The activity probes are instrumental in screening for activators and inhibitors of E3 ubiquitin ligases, as well as interrogating their functional state in human diseases. She has 1 patent to her name.
Career Highlights
Brigit Riley is associated with E3x Bio, Inc., where she continues to advance her research and innovations. Her work is at the forefront of understanding the complexities of ubiquitin ligases and their role in cellular processes.
Collaborations
Brigit collaborates with notable colleagues, including Jennifer Johnston and David Morgans. Their combined expertise enhances the research environment at E3x Bio, Inc.
Conclusion
Brigit Riley's contributions to the field of biotechnology through her innovative patent on ubiquitin ligases exemplify her commitment to advancing scientific knowledge. Her work holds promise for future developments in disease treatment and understanding cellular mechanisms.